Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
25 Jan 2017 | 4:13 AM
 

Claris Lifesciences Ltd. Share Price Live (BSE)
0

BSE Code: 533288 | NSE Symbol:
305.86
2.10
(0.70 %)
24 Jan 2017 | 04:01 PM
Change company
  • Open (Rs)
    304.90
  • Prev. close (Rs.)
    303.75
  • High (Rs.)
    308.70
  • Low (Rs.)
    304.00
  • 52W H (Rs.)
    430.10
  • 52W L (Rs.)
    126.10
  • Volume (Rs.)
    23760
  • MCap (Rs in Cr.)
    1,668.97
  • Open (Rs)
  • High (Rs)
  • Low (Rs)
  • Prev. close(Rs)
  • Contracts Tra.
  • Turnover (Cr.)
  • Open Interest
  • Open Int. chg
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-10.64
Operating Margin (%)
19.29
Gross Profit Margin (%)
13.60
Net Profit Margin (%)
-7.69
Total Debt/Equity
0.42
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

16 Dec 2016 - 11:55:00-Shares of Claris Lifesciences rallied nearly 20 per cent hitting 52-week high on the Bombay Stock Ex...
16 Dec 2016 - 09:37:00-Leading pharma major Claris Lifesciences Ltd has said that it will sell its global generic injectabl...
12 Dec 2016 - 12:13:00-Shares of Claris Lifesciences extended their gain by nearly 7 per cent on the Bombay Stock Exchange ...
29 Aug 2016 - 09:24:00-Leading pharma company Claris Lifesciences and its subsidiaries has received an Abbreviated New Drug...

Announcements

18-Jan-2017
Claris Lifesciences - Advertisement of postal ballot notice
17-Jan-2017
Claris Lifesciences - Notice of Postal Ballot
12-Jan-2017
Claris Lifesciences - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Dec
11-Jan-2017
Claris Lifesciences - Shareholding for the Period Ended December 31 2016
15-Dec-2016
Claris Lifesciences - Claris Lifesciences Limited to Sell Its Global Generic Injectables Business to Baxter for US$ 625 milli

Religare Research

24 Jan 2017 | 12:04 PM
2017-18 Pre Budget Expectations for Currency Markets
24 Jan 2017 | 09:47 AM
The Indian rupee was little changed against the dollar, as demand for the greenback from importers w...
24 Jan 2017 | 09:39 AM
Agri Fundamental report
24 Jan 2017 | 09:39 AM
Agri Technical report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
1,80,897 3.10 52.43 0.66
1,80,897 3.10 31.84 0.66
0 3.10 31.84 0.66
0 3.10 52.43 0.66
1,10,750 2.26 17.54 0.69

Shareholding Pattern

       
Promotors50.13%
Mutual Funds/UTI1.49%
FI/Banks0.00%
Insurance0.00%
FII25.86%
Government0.00%
Others9.42%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,025.00(-1.28)
11816
 Neuland Laboratories Ltd.
975.00(0.29)
3578
 AstraZeneca Pharma India Ltd.
960.25(0.07)
3274
 Merck Ltd.
945.05(0.66)
3302

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Claris Lifesciences Ltd.-1.958.8054.80
NIFTY(S&P CNX)567.55-233.15-159.85
BSE SENSEX1,568.48-803.50-719.76
BSE 500930.67-388.0925.82

Corporate Details

Key Personal
Aditya S Handa
Non Exe.Non Ind.Director
Amish Vyas
Additional Non Exe.Non Ind.Director
Anup P Shah
Non Exe. & Ind. Director
Key Address
Registered Office
Claris Corporate Headquarters Near Parimal Railway Crossing Ellisbridge,Ahmedabad,Gujarat

Tel:079-26563331 66309339, Fax:079-26408053 26565879

investorservices.corp@clarislifesciences.com
http://www.clarislifesciences.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :44 Community Center 2nd Floor Naraina Industrial Area Phase I Near PVR Naraina

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Claris Lifesciences Ltd. that will help you decide whether to buy, sell or hold Claris Lifesciences Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Claris Lifesciences Ltd.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.